Control de factores de riesgo cardiovascular en pacientes diabéticos revascularizados: un subanálisis del estudio ICP-Bypass
Pilar Mazón‐Ramos(Universidade de Santiago de Compostela), Silvia Fernández-Anaya(MSD (Spain)), Alberto Cordero(Hospital Universitari Sant Joan D'Alacant), José Ramón González‐Juanatey(Centro de Investigación en Red en Enfermedades Cardiovasculares), Elías Delgado(Hospital Universitario Central de Asturias), G. Vitale(MSD (Spain))
Cited by 9
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Periodontitis and cardiovascular diseases: Consensus report
|Journal Of Clinical Periodontology|2020|1.5k
Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry
|European Heart Journal|2020|282
Periodontitis and Cardiovascular Diseases. Consensus Report
|Global Heart|2020|274
Patient Phenotype Profiling in Heart Failure with Preserved Ejection Fraction to Guide Therapeutic Decision Making. A Scientific Statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
|European Journal of Heart Failure|2023|187